See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2014_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,716,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,247,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,537,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,538,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 9,974,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,388,000 |
| 9 | ResearchAndDevelopmentExpense | 1,712,000 |
| 10 | remainder_Expenses | 1,402,000 |
| 11 | remainder_Revenues | 30,082,000 |
| 12 | remainder_NetIncome | -305,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 44,500,000 |
| 1 | Liabilities | 3,538,000 |
| 2 | Expenses | 29,476,000 |
| 3 | Revenues | 30,082,000 |
| 4 | StockholdersEquity | 40,962,000 |
| 5 | NetIncome | 301,000 |
| 6 | ComprehensiveNetIncome | 301,000 |
| 7 | BaseVar | 53,950,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.73 |
| 9 | EconomicCapitalRatio | 4.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
